These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17267623)

  • 21. Use of fatty acid RPMI 1640 media for testing susceptibilities of eight Malassezia species to the new triazole posaconazole and to six established antifungal agents by a modified NCCLS M27-A2 microdilution method and Etest.
    Velegraki A; Alexopoulos EC; Kritikou S; Gaitanis G
    J Clin Microbiol; 2004 Aug; 42(8):3589-93. PubMed ID: 15297502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of the disc diffusion method with the broth microdilution and Etest methods for voriconazole susceptibility testing of Aspergillus spp.
    Serrano MC; Ramírez M; Morilla D; Valverde A; Chávez M; Espinel-Ingroff A; Claro R; Fernández A; Almeida C; Martín-Mazuelos E
    J Antimicrob Chemother; 2004 May; 53(5):739-42. PubMed ID: 15056643
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fungal spectrum identified by a new slide culture and in vitro drug susceptibility using Etest in fungal keratitis.
    Qiu WY; Yao YF; Zhu YF; Zhang YM; Zhou P; Jin YQ; Zhang B
    Curr Eye Res; 2005 Dec; 30(12):1113-20. PubMed ID: 16354625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative evaluation of the VITEK 2, disk diffusion, etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains.
    Lo-Ten-Foe JR; de Smet AM; Diederen BM; Kluytmans JA; van Keulen PH
    Antimicrob Agents Chemother; 2007 Oct; 51(10):3726-30. PubMed ID: 17646414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current status of antifungal susceptibility testing methods.
    Arikan S
    Med Mycol; 2007 Nov; 45(7):569-87. PubMed ID: 17885947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating the resistance to posaconazole by E-test and CLSI broth microdilution methodologies of Candida spp. and pathogenic moulds.
    Araujo R; Costa-de-Oliveira S; Coutinho I; Rodrigues AG; Pina-Vaz C
    Eur J Clin Microbiol Infect Dis; 2009 Sep; 28(9):1137-40. PubMed ID: 19350293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quality control and reference guidelines for CLSI broth microdilution susceptibility method (M 38-A document) for amphotericin B, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A; Fothergill A; Ghannoum M; Manavathu E; Ostrosky-Zeichner L; Pfaller M; Rinaldi M; Schell W; Walsh T
    J Clin Microbiol; 2005 Oct; 43(10):5243-6. PubMed ID: 16207990
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [An update on antifungal susceptibility testing].
    Tapia P CV
    Rev Chilena Infectol; 2009 Apr; 26(2):144-50. PubMed ID: 19621145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A; Barchiesi F; Cuenca-Estrella M; Pfaller MA; Rinaldi M; Rodriguez-Tudela JL; Verweij PE
    J Clin Microbiol; 2005 Aug; 43(8):3884-9. PubMed ID: 16081926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility patterns of clinical and fish isolates of Laribacter hongkongensis: comparison of the Etest, disc diffusion and broth microdilution methods.
    Lau SK; Wong GK; Poon RW; Lee LC; Leung KW; Tse CW; Ho PL; Que TL; Woo PC; Yuen KY
    J Antimicrob Chemother; 2009 Apr; 63(4):704-8. PubMed ID: 19202149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F; Patel R; Mann PA; Mendrick CA; Norris CC; Hare R; Loebenberg D; Black TA; McNicholas PM
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2009-15. PubMed ID: 16723559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antifungal activity of posaconazole against Candida spp. and non-Candida clinical yeasts isolates.
    Carrillo-Muñoz AJ; Tur-Tur C; Hernández-Molina JM; Quindós G; Marcos-Arias C; Eraso E; Cárdenes D; Ortiz-Maestro O; Santos P; Estivill D; Guardia C; Giusiano G
    Rev Esp Quimioter; 2010 Sep; 23(3):122-5. PubMed ID: 20844842
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicentre determination of quality control strains and quality control ranges for antifungal susceptibility testing of yeasts and filamentous fungi using the methods of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST).
    Cuenca-Estrella M; Arendrup MC; Chryssanthou E; Dannaoui E; Lass-Florl C; Sandven P; Velegraki A; Rodriguez-Tudela JL;
    Clin Microbiol Infect; 2007 Oct; 13(10):1018-22. PubMed ID: 17697001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Apr; 39(4):1360-7. PubMed ID: 11283057
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro antifungal susceptibility methods and clinical implications of antifungal resistance.
    Espinel-Ingroff A; Warnock DW; Vazquez JA; Arthington-Skaggs BA
    Med Mycol; 2000; 38 Suppl 1():293-304. PubMed ID: 11204157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Standardization of antifungal susceptibility testing and clinical relevance.
    Espinel-Ingroff A; Barchiesi F; Hazen KC; Martinez-Suarez JV; Scalise G
    Med Mycol; 1998; 36 Suppl 1():68-78. PubMed ID: 9988494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of the EUCAST-AFST broth dilution method with the CLSI reference broth dilution method (M38-A) for susceptibility testing of posaconazole and voriconazole against Aspergillus spp.
    Chryssanthou E; Cuenca-Estrella M
    Clin Microbiol Infect; 2006 Sep; 12(9):901-4. PubMed ID: 16882296
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Lau SK; Lo GC; Lam CS; Chow WN; Ngan AH; Wu AK; Tsang DN; Tse CW; Que TL; Tang BS; Woo PC
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of assessment of oxygen consumption, Etest, and CLSI M38-A2 broth microdilution methods for evaluation of the susceptibility of Aspergillus fumigatus to posaconazole.
    Araujo R; Espinel-Ingroff A
    Antimicrob Agents Chemother; 2009 Nov; 53(11):4921-3. PubMed ID: 19704132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.